These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 19053902)
1. Measuring the severity of Clostridium difficile infection: implications for management and drug development. Belmares J; Gerding DN; Tillotson G; Johnson S Expert Rev Anti Infect Ther; 2008 Dec; 6(6):897-908. PubMed ID: 19053902 [TBL] [Abstract][Full Text] [Related]
3. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Khanna S; Pardi DS Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):409-16. PubMed ID: 20678014 [TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile infection in the "oldest" old: clinical outcomes in patients aged 80 and older. Cober ED; Malani PN J Am Geriatr Soc; 2009 Apr; 57(4):659-62. PubMed ID: 19392957 [TBL] [Abstract][Full Text] [Related]
5. Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers. Pakyz A; Carroll NV; Harpe SE; Oinonen M; Polk RE Pharmacotherapy; 2011 Jun; 31(6):546-51. PubMed ID: 21923438 [TBL] [Abstract][Full Text] [Related]
8. Best strategies in recurrent or persistent Clostridium difficile infection. Cocanour CS Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157 [TBL] [Abstract][Full Text] [Related]
9. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. Johnson S J Infect; 2009 Jun; 58(6):403-10. PubMed ID: 19394704 [TBL] [Abstract][Full Text] [Related]
10. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Miller M; Gravel D; Mulvey M; Taylor G; Boyd D; Simor A; Gardam M; McGeer A; Hutchinson J; Moore D; Kelly S Clin Infect Dis; 2010 Jan; 50(2):194-201. PubMed ID: 20025526 [TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options. Lo Vecchio A; Zacur GM Curr Opin Gastroenterol; 2012 Jan; 28(1):1-9. PubMed ID: 22134217 [TBL] [Abstract][Full Text] [Related]
16. Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol. Russell G; Kaplan J; Ferraro M; Michelow IC Pediatrics; 2010 Jul; 126(1):e239-42. PubMed ID: 20547640 [TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile infection in solid organ transplant recipients. Riddle DJ; Dubberke ER Curr Opin Organ Transplant; 2008 Dec; 13(6):592-600. PubMed ID: 19060548 [TBL] [Abstract][Full Text] [Related]
18. [Re-emergent etiologies: Clostridium difficile]. Mare A; Man A; Toma F; Szekely E; Lörinczi L Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):181-8. PubMed ID: 19326731 [TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile Infection. Knight CL; Surawicz CM Med Clin North Am; 2013 Jul; 97(4):523-36, ix. PubMed ID: 23809712 [TBL] [Abstract][Full Text] [Related]